The role of T cell receptor dimerization for T cell antagonism and T cell specificity

Molecular Immunology

Volumn 35, Issue 5, 1998, Pages 271-277

  Salzmann, Michael ^a   Bachmann, Martin F ^a  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL SPECIFICITY; DIMERIZATION; KINETICS; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; DIMERIZATION; EPITOPES, T-LYMPHOCYTE; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 0031868222     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(98)00035-2     Document Type: Article

References (27)

1. Alam, S.M., Travers, P.J., Wung, J.L., Nasholds, W., Redpath, S., Jameson, S.V., Gascoigne, N.R.J., 1996. T cell receptor affinity and thymocyte positive selection. Nature 381, 616-620.
2. Alexander, J., Snoke, K., Ruppert, J., Sidney, J., Wall, M., Southwood, S., Oseroff, C., Arrhenius, T., Gaeta, F.C.G., Colon, S.M., Grey, H.M., Sette, A., 1993. Functional consequences of engagement of the T cell receptor by low affinity ligands. J. Immunol. 150, 1-7.
3. Bachmann, M.F., Oxenius, A., Speiser, D.E., Mariathasan, S., Hengartner, H., Zinkernagel, R.M., Ohashi, P.S., 1997. Peptide induced TCR-down regulation on naive T cell predicts agonist/partial agonist properties and strictly correlates with T cell activation. Eur. J. Immunol. 27, 2195-2203.
4. Bachmann, M.F., Salzmann, M., Oxenius, A., Ohashi, P.S., 1998. T cell receptor dimerization trimerization as a crucial step for T cell activation. In press.
5. Cohn, M., Langman, R.E., 1990. The Protection: The Unit of Humoral Immunity Selected by Evolution. Immunol. Rev. 115, 7-142.
6. DeMagistris, M., Alexander, J., Coggeshall, M., Altman, A., Gaeta, F.C., Grey, H.M., Sette, A., 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68, 625-634.
7. Evavold, B.D., Allen, P.M., 1991. Separation of IL-4 production from T cell proliferation by an altered T cell receptor ligand. Science 252, 1308-1310.
8. Evavold, B.D., Sloan-Lancaster, J., Allen, P.M., 1993. Tickling the TCR: selective T cell functions stimulated by altered peptide ligands. Immunol. Today 14, 602-609.
9. Jameson, S.C., Carbone, F.R., Bevan, M.J., 1993. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177, 1541-1550.
10. Jameson, S.C., Bevan, M.J., 1995. T cell receptor antagonists and partial agonists. Immunity 2, 1-11.
11. Janeway, C.A., 1995. Ligands for the T cell receptor: hard times for avidity models. Immunol. Today 16, 223-225.
12. Janeway, C.A., Medhzhitov, R., Pfeiffer, C., Tao, X., Bottomly, K. 1995. Altered peptide ligands: Conformational changes in the TCR. The Immunologist 3, 41-44.
13. Lenschow, D.J., Walunas, T.L., Bluestone, J. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 259-274.
14. Linsley, P.S., Ledbetter, J.A. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11, 191-212.
15. Lyons, D.S., Lieberman, S.A., Hampl, J., Boniface, J.J., Chien, Y., Berg, L.J., Davis, M.M., 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5, 53-61.
16. Martin, S., Kohler, H., Weltzien, H.U., Leipner, C., 1996. Selective activation of CD8 T cell effector functions by epitope variants of lymphocytic choriomeningitis virus glycoprotein. J. Immunol. 157, 2358-2365.
17. Matsui, K., Boniface, J.J., Steffener, P., Reay, P.A., Davis, M.M., 1994. Kinetics of T cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T cell responsiveness. Proc. Nat. Acad. Sci. U.S.A. 91, 12862-12866.
18. McKeithan, T., 1995. Kinetic proofreading in T cell receptor signal transduction. Proc. Nat. Acad. Sci. U.S.A. 93, 1401-1405.
19. Rabinowitz, J.D., Beeson, C., Lyons, D.S., Davis, M.M., McConnell, H.M., 1996. Kinetic discrimination in T cell activation. Proc. Nat. Acad. Sci. 93, 1401-1405.
20. Reich, Z., Boniface, J.J., Lyons, D.S., Borochov, N., Wachtel, E.J., Davis, M.M., 1997. Ligand-specific oligomerization of T cell receptor molecules. Nature 387, 617-620.
21. Reis-e-Sousa, C., Levine, E.H., Germain, R.N., 1996. Partial signaling by CD8+ T cells in response to antagonist ligands. J.Exp. Med. 184, 149-157.
22. Schwartz, R.H., 1992. Constimulation of T lymphocytes: the role of CD8, CTLA-4, and B7/BB+ in interleukin-2 production and immunotherapy. Cell 71, 1065-1068.
23. Sette, A., Alexander, J., Ruppert, J., Snoke, K., Franco, A., Ishioka, G., Grey, H.M., 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12, 413-431.
24. Sykulev, Y., Brunmark, A., Jackson, M., Cohen, R.J., Peterson, P.A., Eisen, H.N., 1994a. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity 1, 15-22.
25. Sykulev, Y., Brunmark, A., Tsomides, T.J., Kageyama, S., Jackson, M., Peterson, P.A., Eisen, H.N., 1994b. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. U.S.A 91, 11487-11491.
26. Yoon, S.T., Dianzani, U., Bottomly, K., Janeway, C.A., 1994. Both high and low antibodies to the T cell receptor can have agonist or antagonist activity. Immunity 1, 563-569.
27. Zinkernagel, R.M., Doherty, P.C., 1974. Restriction of in vitro T cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248, 701-702.